Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,152 | 68,395 | 155,658 | 76,914 | 33,733 |
| Marketable Securities | 346,725 | 338,771 | 326,250 | 315,395 | 387,079 |
| Other current assets | 3,320 | 2,537 | 2,882 | 2,370 | 1,263 |
| TOTAL | $411,550 | $419,416 | $494,022 | $402,770 | $431,382 |
| Non-Current Assets | |||||
| PPE Net | 17,432 | 13,334 | 12,569 | 12,748 | 11,759 |
| Investments And Advances | 119,017 | 152,328 | 113,701 | 90,182 | 102,478 |
| Other Non-Current Assets | 65,906 | 18,056 | 18,180 | 17,721 | 17,441 |
| TOTAL | $202,355 | $183,718 | $144,450 | $120,651 | $131,678 |
| Total Assets | $613,905 | $603,134 | $638,472 | $523,421 | $563,060 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,483 | 4,335 | 6,327 | 2,374 | 2,567 |
| Accrued Expenses | 18,502 | 27,502 | 24,692 | 21,738 | 20,777 |
| Other current liabilities | 807 | 303 | 710 | 272 | 576 |
| TOTAL | $61,933 | $71,343 | $91,124 | $87,500 | $88,339 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 32,248 | 35,260 | 55,776 | 59,460 | 60,852 |
| Other Non-Current Liabilities | 64,112 | 12,394 | 12,687 | 12,972 | 13,251 |
| TOTAL | $89,967 | $41,640 | $34,463 | $37,970 | $46,001 |
| Total Liabilities | $151,900 | $112,983 | $125,587 | $125,470 | $134,340 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 55,308 | 55,184 | 54,865 | 51,863 | 51,724 |
| Common Shares | 6 | 6 | 6 | 5 | 5 |
| Retained earnings | -424,718 | -383,790 | -348,925 | -305,923 | -265,666 |
| Other shareholders' equity | -3,038 | -4,949 | -5,913 | -3,983 | -3,216 |
| TOTAL | $462,005 | $490,151 | $512,885 | $397,951 | $428,720 |
| Total Liabilities And Equity | $613,905 | $603,134 | $638,472 | $523,421 | $563,060 |